Tokyo, April 20 (Jiji Press)–Panasonic Holdings Corp. said Monday that it has developed an automated system for producing induced pluripotent stem cells, or iPS cells. The company collaborated with Kyoto University-affiliated CiRA Foundation to develop the new system. It plans to commercialize the system in fiscal 2028. While manual production of iPS cells, which are used in regenerative medicine, has faced challenges such as high costs and uneven quality, the automated system is expected to significantly reduce costs. Before commercializing the system, the company will test it on a trial basis at a research facility of the foundation in the western Japan city of Osaka. END [Copyright The Jiji Press, Ltd.]
Panasonic Develops Automated iPS Cell Production System
Related Posts
Japan Joins Balikatan Exercise Hosted by U.S., Philippines
Manila, April 20 (Jiji Press)–Japan’s Ground, Maritime and Air Self-Defense Forces are sending a total of about 1,400 personnel to the Balikatan multilateral exercise jointly organized by the U.S. and Philippine militaries from Monday. This marks Japan’s first full-scale participation in the
EXCLUSIVE: BOJ to Consider Skipping Rate Hike at April Meeting
Tokyo, April 20 (Jiji Press)–The Bank of Japan will consider skipping an additional interest rate hike at its next policy-setting meeting on April 27-28, Jiji Press learned Monday. The anticipated decision reflects persistent uncertainties over prolonged tensions in the Middle East, informed
